B. Metzler seel. Sohn & Co. AG Has $899,000 Holdings in The Clorox Company $CLX

Key Points

• B. Metzler seel. Sohn & Co. AG significantly increased its holdings in The Clorox Company by 107.9%, acquiring an additional 3,169 shares in the first quarter.
• The Clorox Company reported earnings of $2.87 per share, exceeding analysts' estimates by $0.63, alongside a 4.5% year-over-year revenue growth.
• Clorox has announced a quarterly dividend increase to $1.24 per share, representing an annualized payout of $4.96 and a yield of 4.2%.

B. Metzler seel. Sohn & Co. AG increased its stake in The Clorox Company (NYSE:CLX - Free Report) by 107.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,105 shares of the company's stock after acquiring an additional 3,169 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in Clorox were worth $899,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Sonora Investment Management Group LLC boosted its stake in Clorox by 2.5% during the first quarter. Sonora Investment Management Group LLC now owns 2,940 shares of the company's stock valued at $433,000 after buying an additional 72 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in Clorox by 0.6% during the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company's stock valued at $1,953,000 after buying an additional 73 shares in the last quarter. Horizon Investments LLC boosted its stake in Clorox by 4.4% during the first quarter. Horizon Investments LLC now owns 1,768 shares of the company's stock valued at $258,000 after buying an additional 75 shares in the last quarter. Sfmg LLC boosted its holdings in Clorox by 2.8% during the first quarter. Sfmg LLC now owns 2,780 shares of the company's stock worth $409,000 after buying an additional 76 shares in the last quarter. Finally, Financial Avengers Inc. boosted its holdings in Clorox by 32.1% during the fourth quarter. Financial Avengers Inc. now owns 457 shares of the company's stock worth $74,000 after buying an additional 111 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on CLX shares. Barclays reduced their target price on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a report on Tuesday, July 15th. Morgan Stanley reduced their target price on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a report on Friday, August 1st. Citigroup reiterated a "neutral" rating and issued a $135.00 price target (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. JPMorgan Chase & Co. decreased their price target on Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Finally, Jefferies Financial Group decreased their price target on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. One equities research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, Clorox presently has an average rating of "Reduce" and an average target price of $143.36.

Clorox Stock Up 0.9%

Shares of NYSE:CLX traded up $1.15 during trading on Thursday, reaching $124.06. 1,555,055 shares of the company traded hands, compared to its average volume of 1,655,820. The firm has a fifty day simple moving average of $123.87 and a 200 day simple moving average of $133.78. The firm has a market cap of $15.17 billion, a P/E ratio of 19.03, a price-to-earnings-growth ratio of 0.94 and a beta of 0.52. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company's revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the business posted $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th were issued a dividend of $1.24 per share. The ex-dividend date was Wednesday, August 13th. This represents a $4.96 annualized dividend and a dividend yield of 4.0%. This is a positive change from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio is presently 76.07%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.